2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
4 July 2025 - The MHRA has today approved nogapendekin alfa inbakicept (Anktiva) for adults with BCG unresponsive non-muscle invasive bladder ...
2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
2 July 2025 - NICE is unable to make a recommendation on the use of adagrasib (Krazati) for the second-line treatment ...
1 July 2025 - The new approach will ensure that high impact devices, diagnostics and digital tools recommended by NICE, that ...
26 June 2025 - NICE has published additional draft guidance consultation on the use of pegzilarginase in the NHS in ...
20 June 2025 - The MHRA has today approved serplulimab (Hetronifly) to treat adults with extensive-stage small cell lung cancer, which ...
19 June 2025 - The benefits from donanemab (Kisunla; Eli Lilly) and lecanemab (Leqembi; Eisai) - remain too small to justify ...
19 June 2025 - NICE is unable to make a recommendation on the use of tislelizumab (Tevimbra) for the treatment of ...
19 June 2025 - NICE has published final evidence-based recommendations on the use of atezolizumab (Tecentriq) for the adjuvant treatment ...
13 June 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
13 June 2025 - People in England will become the first in the world to receive belantamab mafodotin for this indication ...
23 May 2025 - The Medicines and Healthcare products Regulatory Agency (MHRA) has approved polihexanide (Akantior) to treat acanthamoeba keratitis. ...
23 May 2025 - New treatment sparsentan has been found to slow down the progression of kidney damage, which will change ...
22 May 2025 - Dostarlimab, when used in combination with platinum-based chemotherapy, can be used as an option for the ...